Exact Sciences Names Aaron Bloomer as New Chief Financial OfficerBusiness Wire • 14 days ago
Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024...
Share to Feed
Exact Sciences Corp. (Nasdaq: EXAS) (the Company), a leading provider of cancer screening and diagnostic tests, today announced that on April 10, 2024 it entered into privately negotiated exchange...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present late-breaking data from the first analysis of the ASCEND-2 study demonstrating the...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its first quarter 2024 financial results after the...
Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) EVP Sarah Condella sold 2,000 shares of the business's stock in a transaction dated Monday, April 1st. The stock was sold at an average price of...
Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) fell 4.7% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $70.04 and last traded at $70.24...
Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of an initiative with Mayo Clinic to provide comprehensive genomic profiling and...
Cancer diagnostic specialist Exact Sciences (NASDAQ: EXAS) has lagged the market over the past three years. The pandemic and the economic troubles that followed disrupted the company's operations...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from...